Skip to main content
Erschienen in: European Journal of Epidemiology 8/2009

01.08.2009 | Commentary

Recent and future developments in the epidemiology of the infectious diseases

verfasst von: Didier Raoult

Erschienen in: European Journal of Epidemiology | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Excerpt

Microbiology, that is the unseen living world, is only known very superficially but our knowledge is growing rapidly. This is exemplified by metagenomic studies where all nucleic acids are sequenced from the environment, showing that 70% of sequences obtained from the environment have no match with any database (Eukaryotes, Bacteria, viruses or Archae) [1]. This is measuring objectively our level of ignorance. Therefore understanding now completely human diseases is impossible because of this gap of knowledge of the potential infectious hazards of our environment. This gap of knowledge can result in overinterpretation of currently known factors, if our ignorance is not acknowledged. As a result, conclusions based on statistical tendencies inducted from our current knowledge, will be indeed challenged in the future. Recently new tools such as 16S rDNA amplification and sequencing has allowed the discovery and identification of hundreds of new bacterial pathogens in the 10 last years [2]. As a matter of fact the number of identified bacteria species was multiplied by 4.5. Many viruses were also identified [3]. Diseases caused by these agents could not have been understood before. There is a critical need to close this gap as soon as possible and to invest massively in identification of microorganisms from our body and our environment. The new discovered viruses and microbes will not only allow clarifying the etiology of diseases already considered as caused by microbes, but they will showed to be involved in diseases not currently considered infections such as cancer or obesity. The development of the epidemiology of infectious diseases will develop in my point of view in three major directions in the coming years. …
Literatur
1.
Zurück zum Zitat Raoult D, Forterre P. Redefining viruses: lessons from Mimivirus. Nat Rev Microbiol. 2008;6:315–6.PubMedCrossRef Raoult D, Forterre P. Redefining viruses: lessons from Mimivirus. Nat Rev Microbiol. 2008;6:315–6.PubMedCrossRef
2.
Zurück zum Zitat Janda JM, Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 2007;45:2761–4.PubMedCrossRef Janda JM, Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 2007;45:2761–4.PubMedCrossRef
3.
Zurück zum Zitat Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430:242–9.PubMedCrossRef Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430:242–9.PubMedCrossRef
4.
Zurück zum Zitat Enserink M. Global health. Some neglected diseases are more neglected than others. Science. 2009;323:700.PubMedCrossRef Enserink M. Global health. Some neglected diseases are more neglected than others. Science. 2009;323:700.PubMedCrossRef
5.
Zurück zum Zitat Raoult D, Fournier PE, Drancourt M. What does the future hold for clinical microbiology? Nat Rev Microbiol. 2004;2:151–9.PubMedCrossRef Raoult D, Fournier PE, Drancourt M. What does the future hold for clinical microbiology? Nat Rev Microbiol. 2004;2:151–9.PubMedCrossRef
6.
Zurück zum Zitat Sloots TP, Whiley DM, Lambert SB, Nissen MD. Emerging respiratory agents: new viruses for old diseases? J Clin Virol. 2008;42:233–43.PubMedCrossRef Sloots TP, Whiley DM, Lambert SB, Nissen MD. Emerging respiratory agents: new viruses for old diseases? J Clin Virol. 2008;42:233–43.PubMedCrossRef
7.
8.
Zurück zum Zitat Said MA, Perl TM, Sears CL. Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect Dis. 2008;47:1202–8.PubMedCrossRef Said MA, Perl TM, Sears CL. Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect Dis. 2008;47:1202–8.PubMedCrossRef
9.
Zurück zum Zitat Protano C, Vitali M, Raitano A, Sancin A, Agolini G. Is there still space for the implementation of antisepsis and disinfection to prevent rotavirus and norovirus gastroenteritis outbreaks? J Prev Med Hyg. 2008;49:55–60.PubMed Protano C, Vitali M, Raitano A, Sancin A, Agolini G. Is there still space for the implementation of antisepsis and disinfection to prevent rotavirus and norovirus gastroenteritis outbreaks? J Prev Med Hyg. 2008;49:55–60.PubMed
10.
Zurück zum Zitat Gouriet F, Levy PY, Samson L, Drancourt M, Raoult D. Comparison of the new InoDiag automated fluorescence multiplexed antigen microarray to the reference technique in the serodiagnosis of atypical bacterial pneumonia. Clin Microbiol Infect. 2008;14:1119–27.PubMedCrossRef Gouriet F, Levy PY, Samson L, Drancourt M, Raoult D. Comparison of the new InoDiag automated fluorescence multiplexed antigen microarray to the reference technique in the serodiagnosis of atypical bacterial pneumonia. Clin Microbiol Infect. 2008;14:1119–27.PubMedCrossRef
11.
12.
Zurück zum Zitat Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784–93.PubMedCrossRef Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784–93.PubMedCrossRef
13.
15.
Zurück zum Zitat Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67.PubMedCrossRef Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67.PubMedCrossRef
16.
Zurück zum Zitat Pincock S. Francoise Barre-Sinoussi: shares Nobel Prize for discovery of HIV. Lancet. 2008;372:1377.PubMedCrossRef Pincock S. Francoise Barre-Sinoussi: shares Nobel Prize for discovery of HIV. Lancet. 2008;372:1377.PubMedCrossRef
18.
Zurück zum Zitat Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–4.PubMedCrossRef Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–4.PubMedCrossRef
19.
Zurück zum Zitat Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–131.PubMedCrossRef Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–131.PubMedCrossRef
20.
Zurück zum Zitat Raoult D. Obesity pandemics and the modification of digestive bacterial flora. Eur J Clin Microbiol Infect Dis. 2008;27:631–4.PubMedCrossRef Raoult D. Obesity pandemics and the modification of digestive bacterial flora. Eur J Clin Microbiol Infect Dis. 2008;27:631–4.PubMedCrossRef
21.
Metadaten
Titel
Recent and future developments in the epidemiology of the infectious diseases
verfasst von
Didier Raoult
Publikationsdatum
01.08.2009
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 8/2009
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-009-9361-8

Weitere Artikel der Ausgabe 8/2009

European Journal of Epidemiology 8/2009 Zur Ausgabe